-
Loading metrics
Open Access
Peer-reviewed
Research Article
Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets
-
Fang Zheng ,
¶‡ These authors contributed equally to this work.
Affiliations The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, Medical Research Center, Sun Yat-Sen Memorial Hospital, Guangzhou, China
⨯ -
Yi-Ji Liao ,
¶‡ These authors contributed equally to this work.
Affiliation The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯ -
Mu-Yan Cai ,
¶‡ These authors contributed equally to this work.
Affiliations The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, China
⨯ -
Tian-Hao Liu,
Affiliations The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, Medical Research Center, Sun Yat-Sen Memorial Hospital, Guangzhou, China
⨯ -
Shu-Peng Chen,
Affiliation The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯ -
Pei-Hong Wu,
Affiliations The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, Tumor Interventional Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, China, Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
⨯ -
Long Wu,
Affiliation Department of Clinical Oncology, People’s Hospital, Wuhan University, Wuhan, China
⨯ -
Xiu-Wu Bian,
Affiliation Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing, China
⨯ -
Xin-Yuan Guan,
Affiliations The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, Department of Clinical Oncology, the University of Hong Kong, Hong Kong, China
⨯ -
Yi-Xin Zeng,
Affiliation The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⨯ -
Yun-Fei Yuan,
Affiliations The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, Hepatobiliary Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
⨯ -
Hsiang-Fu Kung,
Affiliations The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, State Key Laboratory of Oncology in South China, the Chinese University of Hong Kong, Hong Kong, China
⨯ -
Dan Xie
* E-mail: xied@mail.sysu.edu.cn
Affiliations The State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China, Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, China
⨯
Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets
- Fang Zheng,
- Yi-Ji Liao,
- Mu-Yan Cai,
- Tian-Hao Liu,
- Shu-Peng Chen,
- Pei-Hong Wu,
- Long Wu,
- Xiu-Wu Bian,
- Xin-Yuan Guan,
- Yi-Xin Zeng
- Published: February 18, 2015
- https://doi.org/10.1371/journal.pgen.1004873